Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Furonteer Co., Ltd. (370090:KRX), powered by AI.
Furonteer Co., Ltd. is currently trading at ₩9,140. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Furonteer Co., Ltd. on Alpha Lenz.
Furonteer Co., Ltd.'s P/E ratio is -12.7.
“Furonteer Co., Ltd. trades at a P/E of -12.7 (undervalued) with modest ROE of -13.9%.”
Ask for details →Furonteer Co., Ltd. is a dynamic player within the biotechnology sector, primarily engaged in the development and commercialization of advanced life science products. The company focuses on creating innovative solutions aimed at genetic research and diagnostics, serving healthcare institutions, research facilities, and laboratories. Furonteer is recognized for its specialized technologies that enhance the precision and efficiency of genetic analysis, significantly contributing to advancements in personalized medicine and therapeutic interventions. The company's products are pivotal in various applications, including disease detection, gene editing, and biomarker discovery, supporting efforts to improve patient outcomes and healthcare services. Furonteer Co., Ltd. plays a significant role in the biotechnology market by driving forward novel research capabilities and facilitating the translation of genetic discoveries into practical applications. With its commitment to research excellence and technological innovation, the company remains an influential entity in shaping the future of medical science and biotechnology.
“Furonteer Co., Ltd. trades at a P/E of -12.7 (undervalued) with modest ROE of -13.9%.”
Ask for details →Furonteer Co., Ltd. (ticker: 370090) is a company listed on KRX in the Industrials sector (Specialty Industrial Machinery). Market cap is $78.2B.
The current price is ₩9,140 with a P/E ratio of -12.71x and P/B of 1.9x.
ROE is -13.92% and operating margin is -58.98%. Annual revenue is $12.1B.